Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Lymphoma

  Free Subscription


26.06.2017

1 Am J Hematol
1 Am J Pathol
2 Blood
1 Br J Cancer
3 Br J Haematol
2 Cancer
1 Int J Cancer
1 J Clin Oncol
2 Leuk Lymphoma
1 Oncology (Williston Park)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. JAIN P, Kantarjian H, Jain N, Short NJ, et al
    Clinical characteristics and outcomes of previously untreated patients with adult onset T-ALL and T-lymphoblastic lymphoma (T-LL) with Hyper-CVAD based regimens.
    Am J Hematol. 2017 Jun 24. doi: 10.1002/ajh.24833.
    PubMed     Text format    


    Am J Pathol

  2. WANG J, Xu-Monette ZY, Jabbar KJ, Shen Q, et al
    Role of AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.
    Am J Pathol. 2017 Jun 13. pii: S0002-9440(17)30187.
    PubMed     Text format     Abstract available


    Blood

  3. NARITA T, Ishida T, Ito A, Masaki A, et al
    Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma.
    Blood. 2017 Jun 23. pii: blood-2016-09-741983. doi: 10.1182/blood-2016-09-741983
    PubMed     Text format     Abstract available

  4. HAVRANEK O, Xu J, Kohrer S, Wang Z, et al
    Tonic B-cell receptor signaling in diffuse large B-cell lymphoma.
    Blood. 2017 Jun 23. pii: blood-2016-10-747303. doi: 10.1182/blood-2016-10-747303
    PubMed     Text format     Abstract available


    Br J Cancer

  5. VAN EGGERMOND AM, Schaapveld M, Janus CP, de Boer JP, et al
    Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
    Br J Cancer. 2017 Jun 20. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Br J Haematol

  6. PRATT G, Yap C, Oldreive C, Slade D, et al
    A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma.
    Br J Haematol. 2017 Jun 23. doi: 10.1111/bjh.14793.
    PubMed     Text format    

  7. STRUSSMANN T, Fritsch K, Baumgarten A, Fietz T, et al
    Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantation.
    Br J Haematol. 2017 Jun 23. doi: 10.1111/bjh.14802.
    PubMed     Text format     Abstract available

  8. SZCZEPANOWSKI M, Lange J, Kohler CW, Masque-Soler N, et al
    Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents.
    Br J Haematol. 2017 Jun 23. doi: 10.1111/bjh.14812.
    PubMed     Text format     Abstract available


    Cancer

  9. HUI L, von Keudell G, Wang R, Zeidan AM, et al
    Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30818.
    PubMed     Text format     Abstract available

  10. CARBONE A, Gloghini A
    Hodgkin lymphoma classification: Are we at a crossroads?
    Cancer. 2017 Jun 16. doi: 10.1002/cncr.30824.
    PubMed     Text format    


    Int J Cancer

  11. SHETZER Y, Napchan Y, Kaufman T, Molchadsky A, et al
    Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors.
    Int J Cancer. 2017;140:1364-1369.
    PubMed     Text format     Abstract available


    J Clin Oncol

  12. GROMMES C, DeAngelis LM
    Primary CNS Lymphoma.
    J Clin Oncol. 2017 Jun 22:JCO2017727602. doi: 10.1200/JCO.2017.72.7602.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  13. LAI C, Roschewski M, Melani C, Pittaluga S, et al
    MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R.
    Leuk Lymphoma. 2017 Jun 22:1-4. doi: 10.1080/10428194.2017.1339882.
    PubMed     Text format    

  14. KIM J, Song YS, Lee JS, Lee WW, et al
    Risk stratification of diffuse large B-cell lymphoma with interim PET-CT based on different cutoff Deauville scores.
    Leuk Lymphoma. 2017 Jun 20:1-8. doi: 10.1080/10428194.2017.1339877.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  15. DUNLEAVY K
    Management of Primary Mediastinal B-Cell Lymphoma and Gray Zone Lymphoma.
    Oncology (Williston Park). 2017;31:499-501.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: